{"id":"95cb8809f6be","type":"article","url":"https://hartvaat.nl/2026/01/19/bloeddrukdoelen-en-niergezondheid-risico-op-nierziekte-door-ras-remmers/","title":"Bloeddrukdoelen en niergezondheid: risico op nierziekte door RAS-remmers","title_en":"Balancing Blood Pressure Targets and Kidney Health: The Potential Risk of Kidney Disease Due to Concentric Arterial and Arteriolar Hypertrophy From Renin-Angiotensin-Aldosterone Inhibitors","category":"hypertensie","category_label":"Hypertensie","professions":["apotheker","huisarts","internist"],"tags":["abelacimab","ace-remmers","aldosteronsynthaseremmers","anemie-ckd","baxdrostat","bloeddrukbehandeling","bradycardie","canagliflozine","cardio-renaal-metabool","endotheel","ezetimibe","figaro-dkd","lorundrostat","perifeer-vaatlijden","ramipril","ras-remmers","renale-denervatie","resistente-hypertensie","resistente-hypertensie-aldosteronremmers","roken","sacubitril-valsartan","slaapapneu"],"journal":"Hypertension","doi":"https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.26125","source_url":"https://doi.org/https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.125.26125","authors":["Lucas Ferreira"],"significance":5,"published":"2026-01-19","source_date":"2026-01-19","image":"","kennis":["https://hartvaat.nl/kennis/hypertensie/hypertensie-en-ckd/","https://hartvaat.nl/kennis/farmacologie/aldosteron-en-raas-farmacologie/"],"congress":"","summary_en":"This perspective discusses the potential risk of kidney disease from concentric arterial and arteriolar hypertrophy caused by renin-angiotensin-aldosterone system inhibitors during intensive blood pressure treatment, highlighting the need to balance blood pressure targets with kidney health.","created":"2026-07-03T10:25:33Z","updated":"2026-07-03T18:38:16Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Bespreking van het potentiële risico op nierziekte door concentrische arteriële en arteriolaire hypertrofie als gevolg van renine-angiotensine-aldosteronsysteem-remmers bij intensieve bloeddrukbehandeling.","abstract_original":"Hypertension, Volume 83, Issue 3, Page e26125, March 1, 2026."}